Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaideep Singh

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
BMC Pharmacology & Toxicology|August 8, 2014
A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefitsTharappel M Anil, Anilkumar Dandu, KrishnaReddy Harsha, et al.
Diabetology & Metabolic Syndrome|August 22, 2014
CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal modelsManoj Kumar Sadasivuni, Bobbili Madhusudhan Reddy, Jaideep Singh, et al.
The Journal of Pediatrics|September 26, 2020
Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trialRonald I Clyman, Joseph Kaempf, Melissa Liebowitz, et al.
The Journal of Pediatrics|October 21, 2018
PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of AgeRonald I Clyman, Melissa Liebowitz, Joseph Kaempf, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 10, 2019
Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)Melissa Liebowitz, Joseph Kaempf, Omer Erdeve, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|July 1, 2025
Indiacran: An Inter-Center Study of Nasolabial Esthetics Outcomes in Patients With Repaired Complete Unilateral Cleft Lip and PalatePuneet Batra, Garima Arora, Abhinav Raj Gupta, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|July 29, 2025
Indiacran: An Inter-Center Assessment of Dental Arch Relationship for Patients with Repaired Complete Unilateral Cleft Lip and PalatePuneet Batra, Garima Arora, Abhinav Raj Gupta, et al.
Orthodontics & Craniofacial Research|June 3, 2026
Indiacran: An Intercentre Assessment of Craniofacial Form for Patients With Repaired Complete Unilateral Cleft Lip and PalatePuneet Batra, Garima Arora, Abhinav Raj Gupta, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
BMC Pharmacology & Toxicology|August 8, 2014
A novel 11β-hydroxysteroid dehydrogenase type1 inhibitor CNX-010-49 improves hyperglycemia, lipid profile and reduces body weight in diet induced obese C57B6/J mice with a potential to provide cardio protective benefitsTharappel M Anil, Anilkumar Dandu, KrishnaReddy Harsha, et al.
Diabetology & Metabolic Syndrome|August 22, 2014
CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal modelsManoj Kumar Sadasivuni, Bobbili Madhusudhan Reddy, Jaideep Singh, et al.
The Journal of Pediatrics|September 26, 2020
Prolonged Tracheal Intubation and the Association Between Patent Ductus Arteriosus and Bronchopulmonary Dysplasia: A Secondary Analysis of the PDA-TOLERATE trialRonald I Clyman, Joseph Kaempf, Melissa Liebowitz, et al.
The Journal of Pediatrics|October 21, 2018
PDA-TOLERATE Trial: An Exploratory Randomized Controlled Trial of Treatment of Moderate-to-Large Patent Ductus Arteriosus at 1 Week of AgeRonald I Clyman, Melissa Liebowitz, Joseph Kaempf, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 10, 2019
Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320)Melissa Liebowitz, Joseph Kaempf, Omer Erdeve, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|July 1, 2025
Indiacran: An Inter-Center Study of Nasolabial Esthetics Outcomes in Patients With Repaired Complete Unilateral Cleft Lip and PalatePuneet Batra, Garima Arora, Abhinav Raj Gupta, et al.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association|July 29, 2025
Indiacran: An Inter-Center Assessment of Dental Arch Relationship for Patients with Repaired Complete Unilateral Cleft Lip and PalatePuneet Batra, Garima Arora, Abhinav Raj Gupta, et al.
Orthodontics & Craniofacial Research|June 3, 2026
Indiacran: An Intercentre Assessment of Craniofacial Form for Patients With Repaired Complete Unilateral Cleft Lip and PalatePuneet Batra, Garima Arora, Abhinav Raj Gupta, et al.
Pageof 10